Categories: December 09

Quant Snapshot: Carmanah Technologies (TSX:CMH)

Underlying data:

1. Price to sales:0.58

As of April 6, 2009 Carmanah had 42,448,652 shares outstanding. The price as of April 6, 2009 was $.79. This gave The Company a market capitalization of $33,534,435.  In the trailing four quarters sales totaled $60.62 million.

2. Cash to market cap:16%

As of Q4, 2008 Carmanah reported cash and short term investments was $7.91 million. Market cap as of April 6, 2009 was $33,534,435.

3. Debt to market cap:0

The Company reported zero long term debt as of Q4, 2008.

4. Three year growth rate: 19.5%

Sales for fiscal 2005 were $38.73 million. Sales grew to $60.62 million in fiscal 2008.

5. Enterprise value to sales: 0.71

The Company’s Enterprise Value as of Q1 2009 was $25.62 million using the formula (market cap + long term debt – cash and short term investments). Sales for the trailing 4Q’s were $60.62 million

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

SuperUser

View Comments

  • This is just a great little company and unlike a few on the DVC list (AAH, TCS) it hasn't run up significantly over the profile price which was .78 cents...actually its dead even...78 cents

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

2 days ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

2 days ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

2 days ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

3 days ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

3 days ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

3 days ago